Crosstalk between Peripheral Small Vessel Properties and Anxious-like Profiles: Sex,Genotype,and Interaction Effects in Mice with Normal Aging and 3×Tg-AD mice at Advanced Stages of Disease
Restricted accessBrief reportFirst published online March 27, 2018
Crosstalk between Peripheral Small Vessel Properties and Anxious-like Profiles: Sex,Genotype,and Interaction Effects in Mice with Normal Aging and 3×Tg-AD mice at Advanced Stages of Disease
Cardiovascular disease resulting from oxidative stress and inflammation can exacerbate Alzheimer’s disease. This brief report provides the first evidence of compromised small peripheral mesenteric resistance artery (MRA) properties in 15-month-old 3xTg-AD mice. Females showed worse physiologically relevant MRA structural (increased passive external and internal diameters, cross sectional area) and functional (increased active internal diameters) alterations suggesting sex-dependent dysfunctions. At both physiological and high intraluminal pressures, vascular alterations correlated with the anxious-like behavioral profile, in a sex-dependent manner. Finally, the results unveil a crosstalk between peripheral small vessel properties and behavior in both 3xTg-AD mice and age-matched counterparts with normal aging.
LinMT, BealMF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature443, 787–795.
2.
HanBH, ZhouML, JohnsonAW, SinghI, LiaoF, VellimanaAK, NelsonJW, MilnerE, CirritoJR, BasakJ, YooM, DietrichHH, HoltzmanDM, ZipfelGJ (2015) Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice. Proc Natl Acad Sci U S A112, E881–E890.
3.
Dá MesquitaS, FerreiraAC, SousaJC, Correia-NevesM, SousaN, MarquesF (2016) Insights on the pathophysiology of Alzheimer’s disease: The crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system. Neurosci Biobehav Rev68, 547–562.
4.
RemarqueEJ, BollenELEM, WeverlingRijnsburgerAWE, LaterveerJC, BlauwGJ, WestendorpRGJ (2001) Patients with Alzheimer’s disease display a pro-inflammatory phenotype. Exp Gerontol36, 171–176.
5.
LaiKSP, LiuCS, RauA, LanctôtKL, KöhlerCA, PakoshM, CarvalhoAF, HerrmannN (2017) Peripheral inflammatory markers in Alzheimer’s disease: A systematic review and meta-analysis of 175 studies. J Neurol Neurosurg Psychiatry88, 876–882.
6.
HolmesC, CunninghamC, ZotovaE, WoolfordJ, DeanC, KerrS, CullifordD, PerryVH (2009) Systemic inflammation and disease progression in Alzheimer disease. Neurology73, 768–774.
7.
EikelenboomP, HoozemansJJ, VeerhuisR, van ExelE, RozemullerAJ, van GoolWA (2012) Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer’s disease. Alzheimers Res Ther4, 15.
8.
LucinKM, Wyss-CorayT (2009) Immune activation in brain aging and neurodegeneration: Too much or too little?Neuron64, 110–122.
9.
SandbrinkR, MastersCL, BeyreutherK (1994) Beta A4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons. J Biol Chem269, 1510–1517.
10.
Van NostrandWE, MelchorJP (2001) Disruption of pathologic amyloid beta-protein fibril assembly on the surface of cultured human cerebrovascular smooth muscle cells. Amyloid8, 20–27.
11.
RoherAE, EshCL, KokjohnTA, CastañoEM, Van VickleGD, KalbackWM, PattonRL, LuehrsDC, DaugsID, KuoYM, EmmerlingMR, SoaresH, QuinnJF, KayeJ, ConnorDJ, SilverbergNB, AdlerCH, SewardJD, BeachTG, SabbaghMN (2009) Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer’s disease. Alzheimers Dement5, 18–29.
12.
SenaCM, PereiraAM, CarvalhoC, FernandesR, SeiçaRM, OliveiraCR, MoreiraPI (2015) Type 2 diabetes aggravates Alzheimer’s disease-associated vascular alterations of the aorta in mice. J Alzheimers Dis45, 127–138.
13.
Fernández-RuizI (2016) Immune system and cardiovascular disease. Nat Rev Cardiol13, 503.
14.
JeffersonAL (2010) Cardiac output as a potential risk factor for abnormal brain aging. J Alzheimers Dis20, 813–621.
15.
TronconeL, LucianiM, CogginsM, WilkerEH, HoCY, CodispotiKE, FroschMP, KayedR, Del MonteF (2016) Aβ amyloid pathology affects the hearts of patients with Alzheimer’s disease: Mind the heart. J Am Coll Cardiol68, 2395–2407.
16.
Navarro-DoradoJ, VillalbaN, PrietoD, BreraB, Martín-MorenoAM, TejerinaT, de CeballosML (2016) Vascular dysfunction in a transgenic model of Alzheimer’s disease: Effects of CB1R and CB2R cannabinoid agonists. Front Neurosci10, 422.
17.
MerliniM, ShiY, KellerS, SavareseG, AkhmedovA, DerungsR, SpeschaRD, KulicL, NitschRM, LüscherTF, CamiciGG (2017) Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer’s disease. Am J Physiol Heart Circ Physiol312, H232–H238.
18.
MulvanyMJ, AalkjaerC (1990) Structure and function of small arteries. Physiol Rev70, 921–971.
19.
OddoS, CaccamoA, ShepherdJD, MurphyMP, GoldeTE, KayedR, MetherateR, MattsonMP, AkbariY, LaFerlaFM (2003) Triple-transgenic model of Alzheimer’s disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron39, 409–421.
20.
Giménez-LlortL, SchiffmannSN, ShmidtT, CanelaL, CamónL, WassholmM, CanalsM, TerasmaaA, Fernández-TeruelA, TobeñaA, PopovaE, FerréS, AgnatiL, CiruelaF, MartínezE, Scheel-KrugerJ, LluisC, FrancoR, FuxeK, BaderM (2007) Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain. Neurobiol Learn Mem87, 42–56.
21.
DantasAP, OnettiY, OliveiraMA, CarvalhoMH, HerasM, VilaE, Jiménez-AltayóF (2014) Western diet consumption promotes vascular remodeling in non-senescent mice consistent with accelerated senescence, but does not modify vascular morphology in senescent ones. Exp Gerontol55, 1–11.
22.
BaumbachGL, HeistadDD (1989) Remodeling of cerebral arterioles in chronic hypertension. Hypertension13, 968–972.
23.
DedeDS, YavuzB, YavuzBB, CankurtaranM, HalilM, UlgerZ, CankurtaranES, AytemirK, KabakciG, AriogulS (2007) Assessment of endothelial function in Alzheimer’s disease: Is Alzheimer’s disease a vascular disease?J Am Geriatr Soc55, 1613–1617.
24.
MulvanyMJ (2012) Small artery remodelling in hypertension. Basic Clin Pharmacol Toxicol110, 49–55.
25.
Giménez-LlortL, ArranzL, MatéI, De la FuenteM (2008) Gender-specific neuroimmunendocrine aging in a triple-transgenic 3xTg-AD mouse model for Alzheimer’s disease. Neuroimmunomodulation15, 331–343.
26.
Jiménez-AltayóF, CaracuelL, Pérez-AsensioFJ, Martínez-RevellesS, MesseguerA, PlanasAM, VilaE (2009) Participation of oxidative stress on rat middle cerebral artery changes induced by focal cerebral ischemia: Beneficial effects of 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6). J Pharmacol Exp Ther331, 429–436.
27.
OnettiY, DantasAP, PérezB, CugotaR, ChamorroA, PlanasAM, VilaE, Jiménez-AltayóF (2015) Middle cerebral artery remodeling following transient brain ischemia is linked to early postischemic hyperemia: A target of uric acid treatment. Am J Physiol Heart Circ Physiol308, H862–H874.
28.
MatéI, CrucesJ, Giménez-LlortL, De la FuenteM (2015) Function and redox state of peritoneal leukocytes as preclinical and prodromic markers in a longitudinal study of triple-transgenic mice for Alzheimer’s disease. J Alzheimers Dis43, 213–226.
29.
Hirata-FukaeC, LiHF, HoeHS, GrayAJ, MinamiSS, HamadaK, NiikuraT, HuaF, Tsukagoshi-NagaiH, Horikoshi-SakurabaY, MughalM, RebeckGW, LaFerlaFM, MattsonMP, IwataN, SaidoTC, KleinWL, DuffKE, AisenPS, MatsuokaY (2008) Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res1216, 92–103.
30.
TarhouniK, GuihotAL, FreidjaML, ToutainB, HenrionB, BaufretonC, PinaudF, ProcaccioV, GrimaudL, AyerA, LoufraniL, LenfantF, ArnalJF, HenrionD (2013) Key role of estrogens and endothelial estrogen receptor α in blood flow-mediated remodeling of resistance arteries. Arterioscler Thromb Vasc Biol33, 605–611.
31.
Giménez-LlortL, MateI, ManassraRM, VidaC, De la FuenteM (2012) Peripheral immune system and neuroimmune communication impairment in a mouse model of Alzheimer’s disease. Ann N Y Acad Sci1262, 74–84.
32.
Giménez-LlortL, Torres-ListaV, De la FuenteM (2014) Crosstalk between behavior and immune system during the prodromal stages of Alzheimer’s disease. Curr Pharm Des20, 4723–4732.
33.
BaggioG, CorsiniA, FloreaniA, GianniniS, ZagonelV (2013) Gender medicine: A task for the third millennium. Clin Chem Lab Med51, 713–727.
34.
CostaG, GarabitoM, Jiménez-AltayóF, OnettiY, SabateM, VilaE, DantasAP (2016) Sex differences in angiotensin II responses contribute to a differential regulation of cox-mediated vascular dysfunction during aging. Exp Gerontol85, 71–80.
35.
Jiménez-AltayóF, SiegertAM, BonorinoF, MeirellesT, BarberàL, DantasAP, VilaE, EgeaG (2017) Differences in the thoracic aorta by region and sex in a murine model of Marfan syndrome. Front Physiol8, 933.
